These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7032783)

  • 1. Heparin.
    Thomas DP
    Clin Haematol; 1981 Jun; 10(2):443-58. PubMed ID: 7032783
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of heparin fractions: some overlooked considerations.
    Fareed J
    Semin Thromb Hemost; 1985 Apr; 11(2):227-36. PubMed ID: 3898374
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term intraperitoneal application of low molecular weight heparin in a continuous ambulatory peritoneal dialysis patient with deep vein thrombosis.
    Schrader J; Tönnis HJ; Scheler F
    Nephron; 1986; 42(1):83-4. PubMed ID: 3941753
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis.
    Doutremepuich C; Bousquet F; Gestreau GL; Toulemonde F; Bayrou B
    Haemostasis; 1987; 17(4):201-5. PubMed ID: 3623263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP; Merton RE; Barrowcliffe TW; Thunberg L; Lindahl U
    Thromb Haemost; 1982 Jun; 47(3):244-8. PubMed ID: 7112499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin.
    Jaques LB
    New Istanbul Contrib Clin Sci; 1973 Oct; 10(4):208-21. PubMed ID: 4132870
    [No Abstract]   [Full Text] [Related]  

  • 7. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antithrombotic and haemorrhagic effects of heparin and a new low molecular weight heparin in rats.
    Andriuoli G; Mastacchi R; Barbanti M; Sarret M
    Haemostasis; 1985; 15(5):324-30. PubMed ID: 4076839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin.
    Bhargava AS; Heinick J; Günzel P
    Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of APTT monitoring of low-dose heparin dosage in hip surgery.
    Poller L; Taberner DA; Sandilands DG; Galasko CS
    Thromb Haemost; 1982 Feb; 47(1):50-3. PubMed ID: 7071805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing the hemorrhagic complications of heparin therapy.
    Penner JA
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1281-9. PubMed ID: 8294317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of heparin in males and females.
    Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
    Clin Invest Med; 1998 Apr; 21(2):71-8. PubMed ID: 9562927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent heparin resistance form elevated factor VIII in a patient with postoperative deep venous thrombosis. A case report.
    Cirisano FD; Lee S; Greenspoon JS
    J Reprod Med; 1996 Mar; 41(3):191-4. PubMed ID: 8778420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of iliofemoral thrombosis in a pregnant patient with heparin resistance.
    Anand SS; Brimble S; Ginsberg JS
    Arch Intern Med; 1997 Apr; 157(7):815-6. PubMed ID: 9125015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis.
    Teo CP; Lim HL; Kueh YK
    Thromb Haemost; 1994 Aug; 72(2):328-9. PubMed ID: 7831676
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin and low molecular weight heparin in thrombosis and beyond.
    Mousa SA
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin: do we understand its antithrombotic actions?
    Cines DB
    Chest; 1986 Mar; 89(3):420-6. PubMed ID: 3512191
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving use of heparin in acute deep venous thrombosis.
    Gold JA; Ferguson CJ; Williams NF; Braun SK
    Wis Med J; 1996 May; 95(5):311-2. PubMed ID: 8936037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.